Summary
This prediction ended on 09.03.21 with a price of €14.97. The BUY prediction by Snowman finished with a performance of 2.21%. Dividends of €0.27 are taken into consideration when calculating the performance. Snowman has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
GSK plc | -1.771% | -1.771% | 4.765% | 9.939% |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
According to Snowman what are the pros and cons of GSK plc for the foreseeable future?
Pros
High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
Medium risks for its business
Market Leader or Top 3
Some uniques
Well known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons
Comments by Snowman for this prediction
In the thread GlaxoSmithKline plc diskutieren
Buy mit Kursziel 17,0
Kursziel geändert auf 17,3
In the thread Trading GlaxoSmithKline plc
Buy beendet